US Broker Ratings

Grifols, S.A. (GRFS) Stock Analysis: A Healthcare Giant with 20% Upside Potential

Grifols, S.A. (GRFS), a key player in the healthcare sector, is capturing attention with its robust growth prospects. Headquartered in Barcelona, Spain, Grifols is renowned for its plasma therapeutic products..

Fresenius Medical Care AG (FMS) Investor Outlook: Analyzing a Potential 20% Upside in the Dialysis Giant

Fresenius Medical Care AG (NYSE: FMS), a leader in the healthcare sector, specifically within the medical care facilities industry, continues to capture investor attention with its robust market presence and..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Strong ROE and Analyst Ratings Signal Investment Opportunity

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leader in the healthcare sector’s diagnostics and research industry, has established itself with a robust market capitalization of $45.45 billion. Headquartered in Westbrook, Maine,..

Avantor, Inc. (AVTR) Stock Analysis: Assessing the 19% Potential Upside

Avantor, Inc. (NYSE: AVTR) presents a compelling narrative for investors seeking exposure in the healthcare sector. Specializing in medical instruments and supplies, Avantor stands out with a significant market cap..

Cardinal Health, Inc. (CAH) Stock Analysis: Assessing a 14.5% Potential Upside for Investors

Cardinal Health, Inc. (NYSE: CAH) stands as a prominent player in the healthcare sector, operating within the medical distribution industry. With its headquarters in Dublin, Ohio, and a global operational..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Unpacking the 9.43% Potential Upside in a Transformative Healthcare Space

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands at the forefront of the medical devices industry, with a specialized focus on digital healthcare solutions aimed at diagnosing cardiac arrhythmias. Headquartered in San..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 16.34% Upside Amidst Robust Revenue Growth

For investors with a keen interest in the biotech sector, BeOne Medicines Ltd. (ONC) presents a compelling opportunity. Based in Basel, Switzerland, BeOne is a prominent player in the oncology..

Elevance Health, Inc. (ELV): Investor Outlook with a 32.54% Potential Upside for Healthcare Giants

Elevance Health, Inc. (NYSE: ELV), a robust player in the healthcare plans sector, presents a compelling investment story for those looking to capitalize on opportunities within the healthcare market. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 70.71% Potential Upside with Robust Buy Ratings

Lantheus Holdings, Inc. (NASDAQ: LNTH) is catching the eyes of savvy investors with a compelling 70.71% potential upside, according to recent analyst ratings. As a stalwart in the healthcare sector,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Evaluating a 4.68% Upside Potential in Healthcare Innovation

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a formidable player in the healthcare sector, specializing in medical devices. With a market capitalization of approximately $13.92 billion, this UK-based company..

Ensign Group, Inc. (ENSG) Stock Analysis: Strong Growth and 10.84% Potential Upside Entice Investors

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, has been catching the eye of investors with its robust growth metrics and promising market position. With..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Innovator with a 5.69% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, focuses on crafting innovative solutions for the biopharma and healthcare industries across the globe. With its headquarters in..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 29.86% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is garnering attention from investors with its strong performance metrics and promising analyst ratings. As a prominent player in the healthcare sector, specifically within..

Jazz Pharmaceuticals (JAZZ): Investor Outlook with a 57% Potential Upside

Jazz Pharmaceuticals plc (JAZZ), a notable player in the biotechnology sector, is capturing investor interest with its promising growth trajectory and robust portfolio of pharmaceutical products. Based in Dublin, Ireland,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Volatility and Future Prospects in the Healthcare Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands out in the healthcare sector as a burgeoning player in the realm of Traditional Chinese Medicine (TCM). With a focus on developing treatments..

West Pharmaceutical Services, Inc. (WST): Investor Outlook on a Healthcare Giant with 19.54% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) is a formidable player in the healthcare sector, specializing in the design, manufacture, and sale of containment and delivery systems for injectable drugs. With..

BioNTech SE (BNTX): Investor Outlook on Biotech Leader with a 17.41% Potential Upside

BioNTech SE (NASDAQ: BNTX) has positioned itself as a significant player in the biotechnology sector, offering promising potential for investors seeking exposure to innovative healthcare solutions. As a leader in..

TG Therapeutics, Inc. (TGTX): Analyst Consensus Highlights Promising Upside in Biotech Sector

Investors seeking opportunities in the dynamic biotechnology sector might want to keep a close eye on TG Therapeutics, Inc. (NASDAQ: TGTX), a company that has recently gained significant attention. With..

Quest Diagnostics (DGX) Stock Analysis: A Healthcare Leader with a 12% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $18.85 billion, Quest..

Medpace Holdings, Inc. (MEDP) Investor Outlook: Navigating the Growth Path Amidst Market Dynamics

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a notable market capitalization of $12.57 billion, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds